Taiwan - Delayed Quote TWD

Lotus Pharmaceutical Co., Ltd. (1795.TW)

227.00
+4.00
+(1.79%)
At close: 1:30:20 PM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
19,115,867
18,584,227
16,957,971
14,632,772
12,649,189
Cost of Revenue
7,579,984
7,660,151
7,574,159
6,826,623
7,009,069
Gross Profit
11,535,883
10,924,076
9,383,812
7,806,149
5,640,120
Operating Expense
5,057,311
4,907,058
4,484,907
3,698,369
3,310,456
Operating Income
6,478,572
6,017,018
4,898,905
4,107,780
2,329,664
Net Non Operating Interest Income Expense
-457,639
-469,328
-525,849
-378,952
-291,495
Pretax Income
6,795,615
6,359,578
5,102,925
3,940,212
1,870,019
Tax Provision
1,330,970
1,294,068
997,299
919,455
466,648
Net Income Common Stockholders
5,464,645
5,065,510
4,105,626
3,020,757
1,403,371
Diluted NI Available to Com Stockholders
5,464,645
5,065,510
4,105,626
3,020,757
1,403,371
Basic EPS
20.86
19.35
15.72
11.59
5.50
Diluted EPS
20.73
19.23
15.67
11.54
5.47
Basic Average Shares
262,031.98
261,850
261,242
260,634.77
255,172
Diluted Average Shares
263,610.68
263,399
262,024
261,764.04
256,685
Total Expenses
12,637,295
12,567,209
12,059,066
10,524,992
10,319,525
Net Income from Continuing & Discontinued Operation
5,464,645
5,065,510
4,105,626
3,020,757
1,403,371
Normalized Income
5,464,219.61
5,063,151.51
4,102,377.98
3,018,200.99
1,429,064.44
Interest Income
102,569
101,437
31,548
3,508
5,344
Interest Expense
560,208
570,765
557,397
382,460
296,839
Net Interest Income
-457,639
-469,328
-525,849
-378,952
-291,495
EBIT
7,355,823
6,930,343
5,660,322
4,322,672
2,166,858
EBITDA
8,674,047
8,213,596
6,870,961
5,259,538
2,926,239
Reconciled Cost of Revenue
7,579,984
7,660,151
7,574,159
6,826,623
7,009,069
Reconciled Depreciation
1,318,224
1,283,253
1,210,639
936,866
759,381
Net Income from Continuing Operation Net Minority Interest
5,464,645
5,065,510
4,105,626
3,020,757
1,403,371
Total Unusual Items Excluding Goodwill
529
2,961
4,037
3,334
-34,237
Total Unusual Items
529
2,961
4,037
3,334
-34,237
Normalized EBITDA
8,673,518
8,210,635
6,866,924
5,256,204
2,960,476
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
103.61
602.51
788.98
777.99
-8,543.56
12/31/2021 - 12/21/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

6472.TW Bora Pharmaceuticals Co., LTD.
733.00
+3.53%
 
6446.TW PharmaEssentia Corporation
508.00
+2.21%
 
3705.TW YungShin Global Holding Corporation
61.80
-0.16%
 
4746.TW Formosa Laboratories, Inc.
67.80
+2.73%
 
4123.TWO Center Laboratories, Inc.
38.25
+3.10%
 
1707.TW Grape King Bio Ltd
136.00
0.00%
 
4119.TW SCI Pharmtech, Inc.
70.80
+1.72%
 
4105.TWO TTY Biopharm Company Limited
75.60
+0.53%
 
1720.TW Standard Chemical & Pharmaceutical Co. Ltd.
58.60
+0.34%
 
6785.TWO Alar Pharmaceuticals Inc.
143.00
-1.38%